| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/03/2003 | WO2002000727A3 Gp286 nucleic acids and polypeptides |
| 01/03/2003 | WO2001098357A3 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 01/03/2003 | CA2489623A1 Atopy |
| 01/03/2003 | CA2451974A1 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | CA2451686A1 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | CA2451625A1 Substituted n-acyl-aniline derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 01/03/2003 | CA2451185A1 Spherical protein particles and methods of making and using them |
| 01/03/2003 | CA2451138A1 Remedies for eosinophilic diseases |
| 01/03/2003 | CA2450969A1 Nucleic acid-associated proteins |
| 01/03/2003 | CA2450758A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | CA2450583A1 Antihistamines for the treatment of nasal congestion and nasal obstruction |
| 01/03/2003 | CA2450562A1 Tyrosine kinase inhibitors |
| 01/03/2003 | CA2450550A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 01/03/2003 | CA2450478A1 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 01/03/2003 | CA2449844A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/02/2003 | US20030004350 Pyrrolo(2,3-b)pyridine derivatives; anticancer and antiproliferative agents |
| 01/02/2003 | US20030004324 31 human secreted proteins |
| 01/02/2003 | US20030004196 Antiinflamamtory agents; autoimmune disease |
| 01/02/2003 | US20030004194 Method for treating fibrotic diseases or other indications VI |
| 01/02/2003 | US20030004189 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides |
| 01/02/2003 | US20030004186 Anticoagulants; cardiovascular disorders; central nervous system disorders |
| 01/02/2003 | US20030004174 Antiinflammatory agents, anticancer agents, antihistamines, central nervous system disorders |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004153 Novel heteroaryl-diazabicycloalkanes |
| 01/02/2003 | US20030004151 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030003516 Therapeutic and diagnostic uses of antibody specificity profiles |
| 01/02/2003 | US20030003169 Prepared by fermenting an aqueous Glycine max (L.) extract with at least one lactic acid bacteria together with at least one yeast |
| 01/02/2003 | US20030003148 Comprises granulated rheology modifying polymers (modified acrylic acid-methacrylic acid homopolymers/copolymers) for making tablets by direct compression, without granulation first; bioavailability |
| 01/02/2003 | US20030003094 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 01/02/2003 | US20030003082 Use of poly-Glu,Tyr and T cells treated therewith for neuroprotective therapy |
| 01/02/2003 | US20030003077 A genetic engineered adenoviral vector contains an adenoviral genome from which the open reading frames E1 and/or E3 were deleted and a therapeutic gene or a DNA sequence that encodes for therapeutic proteins useful in fibrosis treatment |
| 01/02/2003 | EP1270595A1 Gene recombinant antibody and its fragment |
| 01/02/2003 | EP1270577A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 01/02/2003 | EP1270570A1 Amide compounds and use thereof |
| 01/02/2003 | EP1270559A1 Novel imidazole derivatives with anti-inflammatory activity |
| 01/02/2003 | EP1270558A1 "Compound for the treatment of atherosclerotic-thrombotic pathological conditions" |
| 01/02/2003 | EP1270044A2 Wound healing biomarkers |
| 01/02/2003 | EP1269998A1 Composition of prolonged liberation in the form of multiple granules that enables the maintenance of the therapeutic action of 4-nitro-2-phenoximethanesulfonanilide |
| 01/02/2003 | EP1269198A2 Identification of mast/basophil activation inhibitors |
| 01/02/2003 | EP1269196A1 Method of screening for inhibitors of osteopontin |
| 01/02/2003 | EP1268861A2 Diagnosis of diseases associated with dna transcription |
| 01/02/2003 | EP1268857A2 Diagnosis of diseases associated with gene regulation |
| 01/02/2003 | EP1268844A1 Modulating production of pneumococcal capsular polysaccharide |
| 01/02/2003 | EP1268802A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 01/02/2003 | EP1268787A2 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 01/02/2003 | EP1268781A2 G12l, a gene associated with the thermal response |
| 01/02/2003 | EP1268771A1 Human gata-5 transcription factor |
| 01/02/2003 | EP1268555A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 01/02/2003 | EP1268554A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 01/02/2003 | EP1268549A2 Method of identifying inhibitors of tie-2 |
| 01/02/2003 | EP1268489A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidines as antidepressant agents |
| 01/02/2003 | EP1268483A1 Condensed imidazoles as histamine h3 receptor ligands |
| 01/02/2003 | EP1268480A1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 01/02/2003 | EP1268474A2 Substituted 1,3-thiazole compounds, their production and use |
| 01/02/2003 | EP1268471A1 N-heterocyclic derivatives as nos inhibitors |
| 01/02/2003 | EP1268455A2 Piperazine derivatives |
| 01/02/2003 | EP1268453A1 Estrogen agonist/antagonist metabolites |
| 01/02/2003 | EP1268437A1 Inhibitors of protein kinases |
| 01/02/2003 | EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 01/02/2003 | EP1268430A1 Chemical complex compprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 01/02/2003 | EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 01/02/2003 | EP1268096A1 Extrusion die |
| 01/02/2003 | EP1267976A1 Microencapsulated fragrances and methods of coating microcapsules |
| 01/02/2003 | EP1267954A1 Medical devices suitable for gene therapy regimens |
| 01/02/2003 | EP1267945A2 Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor |
| 01/02/2003 | EP1267921A1 Composition and method for the prevention and/or the treatment of allergy |
| 01/02/2003 | EP1267920A2 Cold-adapted equine influenza viruses |
| 01/02/2003 | EP1267915A2 Methods of treating diseases with activated protein c |
| 01/02/2003 | EP1267905A2 Composition for the treatment of heart failure |
| 01/02/2003 | EP1267904A2 Polypeptoid pulmonary surfactants |
| 01/02/2003 | EP1267900A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 01/02/2003 | EP1267876A1 Thrombin inhibitors |
| 01/02/2003 | EP1267870A2 Inhibition of cytokine generation |
| 01/02/2003 | EP1267866A2 The treatment of respiratory diseases |
| 01/02/2003 | EP1267828A2 Pharmaceutical preparations |
| 01/02/2003 | EP1267826A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/02/2003 | EP1139755A4 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 01/02/2003 | EP0980383B1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 01/02/2003 | EP0980382B1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 01/02/2003 | EP0705245B1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 01/01/2003 | CN1388757A Bioavailable dosage form of isotretinoin |
| 01/01/2003 | CN1387890A Chinese medicine granule for treating chronic pharyngitis and its prepn process |
| 01/01/2003 | CN1387870A Rhinitis treating medicine and its prepn |
| 01/01/2003 | CN1387867A Compound medicine for treating dyspneic cough and its production process |
| 01/01/2003 | CN1387864A Medicine for treating stomatocase and throat ache and its prepn |
| 01/01/2003 | CN1097579C Ortho-substituted benzoylguanidines, process for their preparation, use and medicine containing them |
| 01/01/2003 | CN1097459C Diazepino-indoles as phosphodiesterase IV inhibitors |
| 12/31/2002 | US6500936 Glycerol culture of actinomyces |
| 12/31/2002 | US6500864 Disulfide derivatives useful for treating allergic diseases |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators |
| 12/31/2002 | US6500835 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
| 12/31/2002 | US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists |
| 12/31/2002 | US6500818 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/31/2002 | US6500662 Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones |
| 12/27/2002 | WO2002103055A1 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION |
| 12/27/2002 | WO2002102836A2 Moraxella (branhamella) catarrhalis antigens |